Leukemia, commonly known as blood cancer, is a malignant clonal disease of hematopoietic stem cells. There are a large number of leukemia cells in the blood and bones of leukemia patients. They occupy the magpie's nest and occupy the position of hematopoietic cells, causing the patient's body to lose its hematopoietic function, and he can only die in pain. For many years, doctors all over the world have been trying hard to find a cure for leukemia, but there is always a way out. The cure for leukemia was finally found by a Chinese doctor who has been researching for many years. His name is Wang Zhenyi.
In 1924, Wang Zhenyi was born in a well-off family in Shanghai. His father was the manager of Anping Insurance Company. His family was well off and his upbringing was very strict. In addition, Wang Zhenyi has seven brothers and sisters. The whole family lives together in a small three-story bungalow and lives a happy and prosperous life. However, when he was 7 years old, his grandmother unfortunately contracted a cold and died after a long period of treatment. Since then, Wang Zhenyi has established his ideal of studying medicine. At the age of 18, Wang Zhenyi, who had excellent academic performance, got the opportunity to enter Aurora University without taking the exam. He remembered his vow back then and chose medicine without hesitation.
After graduation, Wang Zhenyi put on his beloved white coat. When the war to resist U.S. aggression and aid Korea broke out, Wang Zhenyi joined the medical team to resist U.S. aggression and aid Korea. As the attending physician of the internal medicine tour medical team of the Northeast Military Region, he went to the rear hospital of Boli County, Heilongjiang Treat the wounded. Later, Wang Zhenyi was awarded the second-class merit of the Chinese People's Liberation Army for his timely treatment of more than 60 volunteers suffering from paragonimiasis. After the war, Wang Zhenyi returned to Guangci Hospital and engaged in hematology research. A few years later, Wang Zhenyi encountered a huge problem in his life: leukemia. In 1959, Wang Zhenyi, who continued to make major breakthroughs, confidently put forward the slogan "conquer leukemia within three years". He wanted to overcome technical problems in a short time. However, as more than 60 leukemia patients continued to die, Wang Zhenyi finally realized how naive his ideas were. Therefore, Wang Zhenyi learned from the painful experience and devoted himself to studying leukemia. His wandering life did not stop Wang Zhenyi. He always regarded conquering leukemia as his lifelong goal.
In 1983, Wang Zhenyi got inspiration from a paper by an American expert. There is a type of leukemia cell called "acute promyelocyte" that will regenerate into normal cells under the induction of "13-cis retinoic acid". reverse. However, China at that time was unable to synthesize "13-cis retinoic acid", so Wang Zhenyi had to use "all-trans retinoic acid" as a substitute for experiments. Half a year later, Wang Zhenyi achieved a breakthrough result. "Acute promyelocytes" successfully differentiated into normal cells under the action of all-trans retinoic acid.
One day in 1985, Wang Zhenyi met a 5-year-old girl suffering from leukemia. After a week of chemotherapy, the girl's condition still did not improve. So, at the risk of losing his reputation, Wang Zhenyi tentatively asked the little girl's family if they wanted to try the new medicine he had developed - a bottle of 30 pills costing 13 yuan. The girl's parents acted as doctors and followed Wang Zhenyi's advice. A week later, a 5-year-old girl successfully cured her leukemia by taking all-trans retinoic acid orally.
Later, Wang Zhenyi found patients with similar conditions and rescued 24 leukemia patients in a row, with a recovery rate of over 90%. After the great success, Wang Zhenyi published the research results in the authoritative international hematology journal - "Blood", which caused a shock in the world's medical community. A few years later, Wang Zhenyi once again discovered that arsenic oxide (arsenic) has better curative effects than all-trans retinoic acid, and can achieve a recovery rate of 95%.
It is respectable that although Wang Zhenyi developed a specific drug for leukemia, he gave up the patent. He wanted people all over the world to buy life-saving drugs for only 13 yuan. In 1994, Wang Zhenyi won the Kettering Award from General Motors, which is equivalent to the "Nobel Prize" in the international oncology community, and he was also the first Chinese to win the award. Today, Wang Zhenyi is a 96-year-old man, but he is still committed to leukemia research and has never stopped.